Medications 9 min read

Valproate (Depakote)

Drug class Anticonvulsant / mood stabilizer
Generic Valproic acid / divalproex
Schedule Prescription, not controlled
Half life 9 to 16 hours
Fda year 1978 (Depakote, 1983)
Typical dose 750 to 2000 mg/day, divided

Valproate (Depakote) is a heavy mood stabilizer for acute mania, not ordinary moodiness. The real side effects, labs, and pregnancy risk.

Valproate’s one of the oldest mood stabilizers we still reach for, and it’s got the personality to match. It started out as a seizure drug back in the seventies, somebody noticed the epilepsy patients taking it also got steadier in the mood department, and it’s been pulling double duty ever since. You’ll see it written three different ways on a bottle, valproic acid, divalproex, sodium valproate, and they’re all basically the same molecule wearing slightly different coats. The name most people actually know is Depakote.

Here’s the honest version up front, before we get into the weeds. Valproate’s a real tool and it’s a heavy one. It’s genuinely good at the narrow job it was hired for, which is shutting down a manic episode, and it isn’t something anybody should be handing out because you had a rough couple of weeks and felt moody. If we’re being honest, a chunk of the people who end up on a mood stabilizer never needed one, and another chunk who genuinely did spent years getting told their problem was a character flaw. The field manages to over-prescribe and under-prescribe the same drug at the same time, which takes a certain talent.

Valproate’s a real tool, and it’s a heavy one. Good at the narrow job it was hired for, and not a drug you reach for because you felt moody.

What it actually does

The truthful answer’s that we don’t completely know, which is true of a surprising number of psychiatric drugs and something the field gets weirdly shy about admitting. What we do know is that valproate bumps up GABA, which is the brain’s main calm-down signal, and it slows the sodium channels that let neurons fire over and over in a chain. It pokes at a couple of other systems on the way through. Add it all up and you get a brain that’s harder to shove into the runaway, sped-up, sleep-is-for-the-weak state that defines a manic episode.

That’s the part worth holding onto. Valproate isn’t lifting your mood the way an antidepressant tries to. It’s putting a ceiling on how high and how fast the system can climb. It’s a brake, not a gas pedal, and if you go in expecting it to make you feel good you’re going to be disappointed and probably annoyed.

Who it’s actually for

The strongest evidence, and the reason valproate’s stuck around for forty years, is acute mania and mixed episodes in bipolar I.[1][8] When somebody’s genuinely manic, not busy, not having a good week, but manic, valproate works and it works fast, sometimes in a matter of days instead of the weeks an antidepressant takes. For mixed states, that miserable combination where the engine’s redlining but the mood’s in the gutter, it tends to do better than lithium.

It also gets used for maintenance, to keep the next episode from showing up, though the evidence there’s less clean than lithium’s and that’s worth saying out loud.[2] Outside of psychiatry it’s a solid migraine preventer and still a workhorse seizure medication, so if a neurologist put you on it for headaches and you stumbled onto this page, none of the mood stuff necessarily applies to you.

What it isn’t for is ordinary moodiness, a stretch of bad weeks, or the normal turbulence of being a guy whose life isn’t going the way he wanted. That’s most of what walks through the door, and most of it doesn’t need a mood stabilizer. It needs sleep, some honesty, and usually a conversation nobody wants to have. Valproate’s for a specific, diagnosable, off-the-rails kind of high, and reaching for it short of that’s how people end up thirty pounds heavier for no good reason.

Starting it, and what the first couple of weeks feel like

Most people don’t start at the dose they end up on. You build up to it, partly so your stomach forgives you and partly so we can watch how you respond. The extended-release version, Depakote ER, is once a day, which is the one most people want because nobody likes setting a noon alarm to take a pill at work. When somebody’s acutely manic and we need the brakes on fast, there’s a loading approach that gets you to a working dose in a couple of days, but that’s an inpatient-flavored move, not how a steady outpatient usually begins.

The first week or two’s the worst of it, and that’s worth knowing so you don’t bail early. The stomach stuff, the grogginess, the slightly shaky hands, that’s mostly front-loaded and mostly settles. Somewhere in there we check a blood level, because valproate’s one of the drugs where the number in your bloodstream actually means something. The range we aim for sits somewhere around 50 to 125, and where you land inside it depends on whether we’re chasing down a manic episode or just keeping the lid on. A level that’s too low isn’t doing much, and a level that’s too high is mostly buying you side effects, so the number’s a real tool, not a formality.

The side effects you’ll actually notice

Let’s talk about the ones that make people quit, because they aren’t the ones on the scary warning label. They’re weight and hair.

Valproate puts weight on a lot of people, and not a trivial amount. It nudges appetite up and slows things down metabolically, and for a guy who’s already fighting the scale this can be the dealbreaker that no amount of clinical benefit overcomes. I’d rather say that plainly than have you find out three months and two pant sizes later. The move’s to know it’s coming, watch it from week one, and actually drink water like you like it and keep moving, because passive hoping does nothing here.

Then there’s the hair. Valproate can thin it out, sometimes enough to notice, and for most people it settles down or grows back, but in the meantime it’s unsettling to see more of yourself in the shower drain than you’d like. Some clinicians add a zinc and selenium supplement for it. The evidence’s thin but the downside’s basically nothing. Past those two, the common stuff is a fine hand tremor, some grogginess, and a stomach that isn’t thrilled with you for the first week or two. The tremor and the queasiness usually fade or settle down with a dose tweak.

The scary-sounding ones, in proportion

The label’s got some genuinely serious warnings on it, and the honest job’s to neither wave them away nor turn into Chicken Little about them. The big three are the liver, the pancreas, and your platelets.

Valproate can irritate the liver, can rarely inflame the pancreas, and reliably drags your platelet count down a bit, which matters if you bleed or need surgery.[3] There’s also a quieter one called hyperammonemia, where ammonia builds up and can fog you out or worse even when your liver tests look fine, so brain fog on this drug isn’t something to just push through. None of this is a reason to refuse the drug if you actually need it. It’s the reason we check blood. You get baseline labs, then a valproate level and a look at your liver and platelets at intervals, and that catches almost all of the trouble before it becomes trouble.[4] A drug that needs monitoring isn’t a dangerous drug, it’s a respected one.

Routine blood draw tubes lined up for lab monitoring
The deal with valproate: a few blood draws a year buys you catching the rare problems early.

If you want kids someday

This is the one that genuinely changes the math, and it’s worth slowing down on. Valproate’s one of the more reliably harmful drugs to a developing pregnancy that we still prescribe, linked to neural tube defects and to lower IQ and higher autism risk in kids exposed in the womb.[5] That’s why, for a woman who could get pregnant, it’s close to a last-resort drug and a lot of us will burn through every other option first.

Now, most of the guys reading this are thinking that’s not my problem, and mostly that’s true. But not entirely. European regulators looked at the question of men on valproate around the time of conception and flagged a possible, not proven, bump in the risk of neurodevelopmental problems in the kids.[6] The data’s shakier than the pregnancy data and the experts aren’t in full agreement. The practical version’s this. If you’re a guy on valproate and you and your partner are thinking about a baby in the next year, that’s a real conversation to have with your prescriber, not a footnote to skip. It might change nothing. It might change the plan. Either way you want to know before, not after.

The lamotrigine trap nobody warns you about

One interaction deserves its own section because it bites people. If you’re on valproate and somebody adds lamotrigine, another mood stabilizer, valproate roughly doubles the lamotrigine level by gumming up how it’s cleared.[7] Lamotrigine’s got a rare but serious rash you don’t want, and you dodge it by going up slowly. Stack it on top of valproate without cutting the lamotrigine dose in half and you’ve just doubled the exact thing the slow titration was protecting you from. Anybody who does this for a living knows it cold, but it’s the kind of thing that gets missed when care’s split across two offices that aren’t talking, so it’s worth being the patient who asks.

Where it sits next to lithium

People want to know which mood stabilizer’s better, valproate or lithium, and the honest answer’s that they’re good at slightly different things and the better one’s whichever fits your particular brain. Lithium‘s still the heavyweight for classic, clean bipolar I, it’s got the best evidence for preventing the next episode, and it’s the only thing in this whole conversation that actually lowers suicide risk, which isn’t nothing.[2] The catch’s that lithium’s fussy, it leans on your kidneys and thyroid, and the gap between a working dose and a toxic one’s narrow enough that you’re checking levels for the rest of your life.

Valproate’s the easier one to live with day to day for a lot of people, it tends to win on mixed states and the rapid-cycling pattern where the mood flips fast, and it doesn’t come for your thyroid. What it gives back in the trade is the weight, the hair, and the pregnancy problem we already went through. Neither one’s the obvious default for everybody. Anybody who tells you there’s a single best mood stabilizer for every person is, if we’re being honest, a little full of it.

How to actually think about it

Valproate isn’t a feel-good drug and it isn’t a starter drug. It’s a specific answer to a specific problem, a brain that climbs too high too fast, and inside that problem it’s earned its forty years. If that’s genuinely you, the weight and the hair and the blood draws are a real but manageable price for not having your life detonated by the next manic episode.

If that’s not you, if the word manic’s getting stretched to cover ordinary intensity or a bad stretch, then this is a heavy drug solving a problem you don’t have, and the side effects are all cost and no benefit. The honest question’s never just does this drug work. It’s does this drug fit the actual problem in front of us, and with valproate the gap between the people it fits and the people it gets handed to is wider than it ought to be. That isn’t the drug’s fault. That’s ours.

Sources

FDA prescribing information for valproate via DailyMed, the source for the dosing, pharmacology, half-life, interaction, and side-effect details in this piece.

Therapeutic blood level
50 to 125 µg/mL

The number we actually titrate to. Too low does little, too high mostly buys you side effects. Checked early, then periodically.

Time to work in mania
Days, not weeks

Unlike an antidepressant, valproate can pull a genuine manic episode down fast. That speed is exactly why it earns its place for acute mania.

What men flag most
Weight and hair

Not the scary label warnings. The two side effects that actually make guys quit are appetite-driven weight gain and temporary hair thinning.

  1. Lancet Cipriani A, et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet. 2011;378(9799):1306-1315.
  2. Lancet / BMJ BALANCE investigators. Lithium plus valproate versus monotherapy for relapse prevention in bipolar I disorder (BALANCE). Lancet. 2010;375(9712):385-395. On lithium's anti-suicide effect: Cipriani A, et al. Lithium in the prevention of suicide in mood disorders. BMJ. 2013;346:f3646.
  3. FDA Label Depakote (divalproex sodium) Prescribing Information. Boxed warnings for hepatotoxicity and pancreatitis; dose-related thrombocytopenia.
  4. APA American Psychiatric Association. Practice Guideline for the Treatment of Patients With Bipolar Disorder (baseline and periodic liver tests, CBC with platelets, and valproate level).
  5. Lancet Neurol / Cochrane Meador KJ, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study). Lancet Neurology. 2013;12(3):244-252. See also Bromley R, et al. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child. Cochrane Database Syst Rev. 2014;(10):CD010236.
  6. EMA European Medicines Agency, PRAC. Valproate: precautionary measures for use in male patients regarding a possible risk to offspring. 2024.
  7. FDA Label Lamotrigine (Lamictal) Prescribing Information: valproate roughly doubles lamotrigine serum levels; the lamotrigine dose must be reduced and titrated slowly to lower the risk of serious rash.
  8. Cochrane Jochim J, Rifkin-Zybutz RP, Geddes J, Cipriani A, Valproate for acute mania, Cochrane Database of Systematic Reviews, 2019, Issue 10, CD004052.